COMMUNIQUÉS West-GlobeNewswire

The Cost of Loneliness Project Announces a Journey Across America Leading to the First National Day of Connection on Nov. 12
02/09/2026
Founder Lucy Rose begins Walk With Me, a two-month journey through more than 45 communities in 17 states, calling on every American to join a new national tradition: Take 12 at 12 on Nov. 12 WINSTON-SALEM, N.C., Sept. [...]
Revived Smiles Broadens Access to Custom Partial Dentures With New Financing Option
02/09/2026
Photo Courtesy by Revived Smiles LOS ANGELES, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Consumers who need custom partial dentures but can't cover the full cost at once now have a new payment option available. Revived Smiles, [...]
Rise Recovery Names Karla Ramirez CEO Following Expansion of Youth Recovery Services
02/09/2026
Behavioral health leader to guide organization's continued expansion of recovery, treatment and educational services for youth and families SAN ANTONIO, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rise Recovery today [...]
K-Diet Launches Personalized Korean Diet App With Over 1,000+ Recipes and Built-In Tracking
02/09/2026
New K-Diet App Turns a Short Quiz Into a Korean-Inspired Meal Plan NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- K-Diet has launched a personalized Korean diet and wellness app built around customized meal plans and [...]
Ozari Health Expands Pharmacy Transparency With Hallandale Pharmacy Profile on National Telehealth Platform
02/09/2026
New pharmacy standards resource gives patients clearer information about Hallandale Pharmacy, one of the compounding pharmacies used to fulfill eligible prescriptions through Ozari Health New York, NY, Sept. 02, 2026 ( [...]
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
02/09/2026
Company announcement No. 45 / 2026 Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, September 2, 2026 – Zealand Pharma A/S ("the Company" or “Zealand [...]
By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor
02/09/2026
After a limited-edition launch sparked strong consumer demand, the nostalgic red-white-and-blue flavor joins the Popsicle Hard lineup year-round NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray [...]
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting
02/09/2026
WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal [...]
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
02/09/2026
Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth [...]
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
02/09/2026
Topline data from Phase 1/2 Cohort 1 of OPGx-BEST1 gene therapy program to be presented during investor conference call and webcast on September 9 at 8:00 a.m. ET Full clinical dataset and additional analyses evaluating [...]
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential
02/09/2026
Teva-discovered TEV ‘408, a novel anti-IL-15 monoclonal antibody, demonstrated statistically significant and clinically meaningful prevention of gluten-induced intestinal damage vs placebo following a single [...]
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
02/09/2026
-- Significant New Program Positioned to Become One of Lifecore’s Largest Contracts -- -- Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Drug Product -- -- Program Expected to [...]
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
02/09/2026
~ Company also announces the submission of a Marketing Authorisation Application for ifezuntirgene inilparvovec in the U.K. ~ ~ Both submissions are supported by the three-year data analysis from the Phase I/II study, [...]
Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.
02/09/2026
Agreement broadens access to revyve® advanced wound care products through an established Canadian medical supply distributor WINNIPEG, Manitoba, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “ [...]
Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
02/09/2026
TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach ® Blue [...]
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
02/09/2026
PALO ALTO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for [...]
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
02/09/2026
SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced that the company’s management will be attending and presenting at the H.C. Wainwright 28 th Annual Global Investment Conference [...]
Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences
02/09/2026
WAYNE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc . (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Dyne Therapeutics to Participate in Upcoming Investor Conferences
02/09/2026
WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]

Pages